NCT04519138 is a NA clinical trial of Endodrill Model X in Tumor Sampling, sponsored by Region Skane.

Who is sponsoring NCT04519138?

NCT04519138 is sponsored by Region Skane.

What drugs are being tested in NCT04519138?

Interventions in NCT04519138: Endodrill Model X, Fine-needle aspiration/biopsy.

What condition does NCT04519138 study?

NCT04519138 studies Tumor Sampling.

Is NCT04519138 still recruiting?

NCT04519138 is currently completed. Last updated 2 December 2021.

Last reviewed 2021-12-02 · How we verify

NCT04519138

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation to Evaluate Safety and Efficacy of the Endodrill Model X Biopsy Instrument

Completed NA Last updated 2 December 2021

What this trial tests

NA trial testing Endodrill Model X in Tumor Sampling in 7 participants. Completed in 30 November 2021.

Timeline

30 September 2020

Primary endpoint
30 November 2021

30 November 2021

Quick facts

Lead sponsor	Region Skane
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	diagnostic
Enrollment	7
Start date	30 September 2020
Primary completion	30 November 2021
Estimated completion	30 November 2021
Sites	3 locations across Sweden

Drugs / interventions tested

Endodrill Model X
Fine-needle aspiration/biopsy

Conditions studied

Tumor Sampling — all drugs for Tumor Sampling →

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Tumor Sampling. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an investigator led prospective open label investigation, performed at three clinics in Sweden, comparing the flexible endoscopic biopsy instrument Endodrill Model X with the standard sampling method endoscopic ultrasound fine needle aspiration/biopsy. Assessment of safety is the primary objective and performance is the secondary objective.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Region Skane trials

Trials by the same sponsor.

NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04519138 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Skane
Last refreshed: 2 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04519138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing